AstraZeneca Pharma India Limited (ASTRAZEN.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 194.13B |
| Enterprise Value | 190.75B |
| P/E Ratio | 89.2 |
| PEG Ratio | -11.92 |
| Price/Sales Ratio | 6.22 |
| Price/Book Ratio | 17.34 |
| Enterprise/Revenue | 6.22 |
| Enterprise/EBITDA | 62.46 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.2 |
Income Statement
| Revenue | 22.76B |
| Revenue/Share | 972.82 |
| Gross Profit | 6.02B |
| EBITDA | 2.85B |
| Net Income | 1.88B |
| Diluted EPS | 75.01 |
Balance Sheet
| Total Cash | 4.48B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 349.12 |
Price History
| 52-Week Change | -34.93 |
| 52-Week High | 9,849.5 |
| 52-Week Low | 5,640 |
| Moving Average 50 Days | 6,726.34 |
| Moving Average 200 Days | 7,987.19 |
Statistics
| Average Volume | 12,961 |
| Shares Outstanding | 25M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 36 |
| Trailing Annual Dividend Yield | 0.59 |
| Payout Ratio | 0.47 |
| Last Split Factor | 5:1 |
| Last Split Date | June 15, 2006 |
AD
